How Innovative Treatments are Shaping the China Benign Prostatic Hyperplasia Market
The China Benign Prostatic Hyperplasia Treatment Market is evolving rapidly, with a projected market size of approximately USD 1,346.34 million by 2035. This remarkable growth, at a compound annual growth rate (CAGR) of 5.5%, reflects not only the increasing prevalence of benign prostatic hyperplasia among the aging male population but also the rising demand for minimally invasive treatment...
0 Comments 0 Shares 2 Views 0 Reviews